AG
Therapeutic Areas
Novakand Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Rugocrixan | Inflammatory diseases / Cancer | Clinical |
| Fosrugocrixan | Inflammatory diseases / Cancer | Clinical |
Leadership Team at Novakand Pharma
PS
Peter Selin
CEO
EN
Erik Nerpin
Chairman of the Board
TO
Thomas Olin
Senior Scientific Advisor, Board Member